Epinephrine's Dose-Dependent Effects on Adrenergic Receptors
Receptor Activity Profile
- Epinephrine exhibits clear dose-dependent effects on adrenergic receptors, with low-dose infusions (<0.3 mcg/kg per minute) predominantly producing beta-adrenergic effects (both beta-1 and beta-2), while higher-dose infusions (>0.3 mcg/kg per minute) cause more alpha-adrenergic vasoconstriction 1
- At low doses, epinephrine predominantly activates beta-1 and beta-2 receptors, with beta-2 effects being more prominent 1, 2
- As the dose increases, alpha-adrenergic effects become more pronounced, leading to vasoconstriction 1
Beta-1 Receptor Effects
- Stimulation of beta-1 receptors by epinephrine results in increased heart rate (chronotropic effect), enhanced cardiac contractility (inotropic effect), improved cardiac conduction, and increased cardiac output 2, 3
Beta-2 Receptor Effects
- Stimulation of beta-2 receptors by epinephrine causes bronchodilation through relaxation of bronchial smooth muscle, vasodilation in skeletal muscle and coronary vessels, decreased peripheral vascular resistance at low doses, and increased stroke volume through coronary vessel dilation 2, 3, 4
Dose-Dependent Relationship
- Low-dose epinephrine (<0.3 mcg/kg/min) predominantly activates beta-adrenergic receptors, causes vasodilation through beta-2 effects, increases heart rate and cardiac output, and decreases systemic vascular resistance 1, 2
- High-dose epinephrine (>0.3 mcg/kg/min) causes alpha-adrenergic effects to become dominant, leading to vasoconstriction, and may increase blood pressure significantly 1, 2
Clinical Implications
- In anaphylaxis, epinephrine works through multiple mechanisms, including alpha-1 effects increasing vascular resistance and decreasing mucosal edema, beta-1 effects increasing cardiac output, and beta-2 effects causing bronchodilation and decreasing inflammatory mediator release 3
- Beta-blockers can significantly alter epinephrine's effects, with non-selective beta-blockers blocking both beta-1 and beta-2 receptors, potentially leaving alpha effects unopposed, and selective beta-1 blockers allowing some beta-2 effects to persist 5